Income Tax Department Imposes Rs 57.74 Crore Penalties on Emcure Pharmaceuticals for Seven Financial Years:

Emcure Pharmaceuticals faces a total Rs 57.74 crore income tax penalty for FY2014-15 to FY2020-21 and is evaluating legal options to appeal the orders.

Emcure Pharma Faces Rs 57.74 Cr Tax Penalty

Vanshika verma

Oct 5, 2026

Last update on Oct 5, 2026

Emcure Pharmaceuticals Limited has received multiple orders from the Income Tax Department for financial years 2014-15 to 2020-21 imposing a total penalty of Rs 57.74 crore.

The company revealed the development in a filing to the stock exchanges on October 2, 2026. The penalties relate to assessment years 2015-16 to 2021-22 and are linked to ongoing tax litigation which Emcure had earlier disclosed.

The orders were passed by the Deputy Commissioner of Income Tax, Central Circle 2(1), Pune, the company said. The lawsuit was filed on December 27, 2023.

Emcure said that it is examining its legal options and may file an appeal before the Appellate Authority against the orders.

The company has disclosed the ongoing litigation in its Integrated Governance Reports, the latest disclosure relating to the quarter ended June 30, 2026.

The latest orders cover a period of seven years, FY2014-15 to FY2020-21, and the total penalty comes to Rs 57,73,96,732.

About Author

Vanshika verma

Content Writer

Vanshika Verma is a Content Writer with 1+ year of experience at Studycafe.in. A B.Com graduate from Delhi University, She writes articles on Finance, Tax, ICAI, GST, and the latest financial news, with a focus on making complex topics easy for readers and professionals.